Causal Inference for Continuous Multiple Time Point Interventions

Stat Med. 2024 Dec 10;43(28):5380-5400. doi: 10.1002/sim.10246. Epub 2024 Oct 17.

Abstract

There are limited options to estimate the treatment effects of variables which are continuous and measured at multiple time points, particularly if the true dose-response curve should be estimated as closely as possible. However, these situations may be of relevance: in pharmacology, one may be interested in how outcomes of people living with-and treated for-HIV, such as viral failure, would vary for time-varying interventions such as different drug concentration trajectories. A challenge for doing causal inference with continuous interventions is that the positivity assumption is typically violated. To address positivity violations, we develop projection functions, which reweigh and redefine the estimand of interest based on functions of the conditional support for the respective interventions. With these functions, we obtain the desired dose-response curve in areas of enough support, and otherwise a meaningful estimand that does not require the positivity assumption. We develop g $$ g $$ -computation type plug-in estimators for this case. Those are contrasted with g-computation estimators which are applied to continuous interventions without specifically addressing positivity violations, which we propose to be presented with diagnostics. The ideas are illustrated with longitudinal data from HIV positive children treated with an efavirenz-based regimen as part of the CHAPAS-3 trial, which enrolled children < 13 $$ <13 $$ years in Zambia/Uganda. Simulations show in which situations a standard g-computation approach is appropriate, and in which it leads to bias and how the proposed weighted estimation approach then recovers the alternative estimand of interest.

MeSH terms

  • Alkynes / therapeutic use
  • Anti-HIV Agents* / therapeutic use
  • Benzoxazines* / administration & dosage
  • Benzoxazines* / therapeutic use
  • Causality
  • Child
  • Computer Simulation*
  • Cyclopropanes* / therapeutic use
  • Dose-Response Relationship, Drug
  • HIV Infections* / drug therapy
  • Humans
  • Longitudinal Studies
  • Models, Statistical
  • Zambia

Substances

  • efavirenz
  • Anti-HIV Agents
  • Cyclopropanes
  • Benzoxazines
  • Alkynes